Funder: European Commission
Due Dates: April 13, 2027 (first-stage) | September 22, 2027 (second-stage)
Funding Amounts: €5–7 million per project; ~6 projects funded; lump sum; project duration typically 3–5 years
Summary: Supports the development of advanced, user-friendly point-of-care diagnostic devices to accelerate clinical decision-making and improve patient outcomes, especially in resource-limited settings.
Key Information: Two-stage, blind evaluation; clinical validation and regulatory alignment required; proposals must address technical, clinical, and value-based criteria.